Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.

The clinical course of breast cancer was related to degree of anaplasia (DA) and steroid receptor (SR) content of primary tumours in 743 patients (pts) with clinical recurrence, initially enrolled in the DBCG-77 protocols. The oestrogen receptor (ER) and the progesterone receptor (PgR) content was known in 110 and 67 pts. The recurrence-free interval, survival after recurrence, and the overall survival were all prolonged in patients with well differentiated tumours or with high SR content. The tumour growth rates were estimated as clinical rates of progression (i.e., the time elapsed from a single distant metastasis until dissemination). The progression rate was prolonged in relatively well differentiated as well as in receptor rich tumours. The extent of dissemination, as indicated by the number of metastatic sites, was not associated with either DA or SR content. However, the anatomical distribution of metastases varied with both DA and SR content: signs of poor prognosis (high DA or low SR content) were associated with occurrence of visceral metastases. In contrast, SR rich tumours had a propensity for recurrence in bone. The results suggest that the impact on prognosis of the features examined here includes both variations in growth rate and metastatic pattern.

• Publication year

  1988

• Venue

  British Journal of Cancer

• Publication date

  1988-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.1988.245PMID 3207602PMCID 2246791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic implication of estrogen receptor content in breast cancer

  2005cited by this paper
• Curability of breast cancer.

  1991cited by this paper
• Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancer.

  1988cited by this paper
• Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low‐risk carcinomas from a multicenter trial

  1987cited by this paper
• The clinical course of bone metastases from breast cancer.

  1987cited by this paper
• Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

  1987cited by this paper
• Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

  1987cited by this paper
• Stage and pattern of metastases in patients with breast cancer.

  1987cited by this paper
• An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer.

  1986cited by this paper
• Survival after first recurrence in breast cancer.

  1986cited by this paper
• Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.

  1986cited by this paper
• Tamoxifen and contralateral breast cancer.

  1985cited by this paper
• Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.

  1985cited by this paper
• Estrogen receptors and the pattern of relapse in breast cancer.

  1984cited by this paper
• Assessment of response of bone metastases to systemic treatment in patients with breast cancer

  1983cited by this paper
• Epidemiologic Research: Principles and Quantitative Methods.

  1983cited by this paper
• Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer.

  1982cited by this paper
• Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.

  1981cited by this paper
• Selection of High Risk Groups Among Prognostically Favorable Patients with Breast Cancer: An Analysis of the Value of Prospective Grading of Tumor Anaplasia in 1,048 Patients

  1981cited by this paper
• Estrogen receptor: A prognostic factor in breast cancer

  1981cited by this paper
• Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer.

  1981cited by this paper
• Organisation of the Danish adjuvant trials in breast cancer.

  1981cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

  1980cited by this paper
• Clinical application of estrogen receptor in breast cancer

  1980cited by this paper
• Analysis of reproducibility of subjective grading systems for breast carcinoma.

  1979cited by this paper
• Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancer

  1977cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade.

  1976cited by this paper
• The surgical implications of estrophile protein estimations in carcinoma of the breast.

  1976cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper
• Is there an increased risk?

  1954cited by this paper

• Breast Cancer Pathology, Receptor Status, and Patterns of Metastasis in a Rural Appalachian Population

  2014cites this paper
• Reproductive factors with respect to breast cancer risk and breast cancer survival

  2014cites this paper
• Principles of Breast Cancer Therapy

  2010cites this paper
• The properties of high-dimensional data spaces: implications for exploring gene and protein expression data

  2008cites this paper
• The Prognostic Factors for Tumor Metastasis to Bone from Breast Cancer and Survival for Breast Cancer Patients after Bone Metastasis

  2008cites this paper
• Cancer Treatment and Research

  2005cites this paper
• Prognostic factors for bone metastases in breast cancer

  2004cites this paper
• Bisphosphonate actions on bone and visceral metastases.

  2004cites this paper
• Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update

  2004cites this paper
• Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.

  2002cites this paper
• Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.

  2002cites this paper
• Behaviour of estrogen receptor, histological correlation, and clinical outcome in patients with benign breast disorders.

  2002cites this paper
• Preclinical models of bone metastases.

  2001cites this paper
• Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases.

  2000cites this paper
• Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma

  2000cites this paper
• Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

  2000cites this paper
• Progesterone Receptors in Normal and Neoplastic Breast

  2000cites this paper
• Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

  1999cites this paper
• Histological Factors Associated with Initial Bone Metastasis of Invasive Ductal Carcinoma of the Breast

  1999cites this paper
• The effect of body mass index and oestrogen receptor level on survival of breast cancer patients.

  1997cites this paper
• Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

  1997cites this paper
• Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.

  1997cites this paper
• 137 Lokalrezidive nach Mammakarzinom - Eine retrospektive Untersuchung

  1996cites this paper
• [137 local recurrences after breast carcinoma--a retrospective study].

  1996cites this paper
• Estradiol receptors and metastasis in human breast cancer.

  1996cites this paper
• The natural history of operable breast cancer after primary treatment.

  1995cites this paper
• Prognostic value of steroid hormone receptors concentration in patients with endometrial Carcinoma

  1994cites this paper
• Determination of estrogen receptors in paraffin‐embedded tissue: Techniques and the value in breast cancer treatment

  1994cites this paper
• Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma.

  1994cites this paper
• p53 protein and vimentin in invasive ductal NOS breast carcinoma--relationship with survival and sites of metastases.

  1994cites this paper
• Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study

  1993cites this paper
• Differential influence of prognostic factors on the occurrence of metastases at various anatomical sites in human breast cancer.

  1992cites this paper
• Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

  1992cites this paper
• Determination of Estrogen Receptors in Paraffin-Embedded Tissue: Techniques and the value in breast cancer treatment

  1992cites this paper
• Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer.

  1991cites this paper
• pS2 expression and response to hormonal therapy in patients with advanced breast cancer.

  1991cites this paper
• Steroid receptors in breast cancer

  1991cites this paper
• Prognostic indicators of metastatic bone disease in human breast cancer

  1991cites this paper
• The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors.

  1990cites this paper
• Nuclear and "cytoplasmic" estrogen and progesterone receptors in squamous cell carcinoma of the cervix.

  1990cites this paper
• Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.

  1989cites this paper
• Body size and menopausal status in relation to the pattern of spread in recurrent breast cancer.

  1989cites this paper